Clinical Trial Update: A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tarceva (erlotinib) in combination with Avastin (bevacizumab) for advanced or metastatic liver cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-14